Thyrocare Board Meeting on Oct 29 to Approve Q2 FY27 Results

Thyrocare Technologies Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda item is the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. Concurrently, the company has closed its trading window from October 1, 2026, for designated persons and their immediate relatives, adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window is set to reopen 48 hours post the declaration of the financial results.